Cargando…

Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States

IMPORTANCE: Pharmacist-led interventions can significantly improve blood pressure (BP) control. The long-term cost-effectiveness of pharmacist-prescribing interventions implemented on a large scale in the US remains unclear. OBJECTIVE: To estimate the cost-effectiveness of implementing a pharmacist-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixon, Dave L., Johnston, Karissa, Patterson, Julie, Marra, Carlo A., Tsuyuki, Ross T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625044/ https://www.ncbi.nlm.nih.gov/pubmed/37921763 http://dx.doi.org/10.1001/jamanetworkopen.2023.41408

Ejemplares similares

Cost-effectiveness of pharmacist care for managing hypertension in Canada
por: Marra, Carlo, et al.
Publicado: (2017)

Outcomes of Urinary Tract Infection Management by Pharmacists (R(x)OUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community
por: Beahm, Nathan P., et al.
Publicado: (2018)

Canadian national consensus guidelines for naloxone prescribing by pharmacists
por: Tsuyuki, Ross T., et al.
Publicado: (2020)

Improving hypertension management through pharmacist prescribing; the rural alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods
por: Charrois, Theresa L, et al.
Publicado: (2011)

Effect of Pharmacist Email Alerts on Concurrent Prescribing of Opioids and Benzodiazepines by Prescribers and Primary Care Managers: A Randomized Clinical Trial
por: Sacarny, Adam, et al.
Publicado: (2022)

Patterns in Outpatient Benzodiazepine Prescribing in the United States
por: Agarwal, Sumit D., et al.
Publicado: (2019)

Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists
por: Sanyal, Chiranjeev, et al.
Publicado: (2019)

Comparison of Opioid Prescribing by Dentists in the United States and England
por: Suda, Katie J., et al.
Publicado: (2019)

1957. Pharmacist Prescribing and Care in Patients with Uncomplicated Urinary Tract Infections in the Community: Efficacy and Safety Outcomes of the R(x)OUTMAP Study
por: Beahm, Nathan, et al.
Publicado: (2018)

Opioid Prescribing After Surgery in the United States, Canada, and Sweden
por: Ladha, Karim S., et al.
Publicado: (2019)

200. Pharmacist Prescribing and Care for Patients with Uncomplicated Urinary Tract Infections in the Community: Antimicrobial Utilization and Stewardship Results of the R(x)OUTMAP Study
por: Beahm, Nathan, et al.
Publicado: (2018)

Pharmacist interventions to improve hypertension management: protocol for a systematic review of randomised controlled trials
por: Gastens, Viktoria, et al.
Publicado: (2022)

Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016
por: Soprano, Samantha E., et al.
Publicado: (2020)

The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspective
por: Jay, Jessica S, et al.
Publicado: (2021)

Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017
por: Schieber, Lyna Z., et al.
Publicado: (2019)

Pharmacist-Driven Transitions of Care Practice Model for Prescribing Oral Antimicrobials at Hospital Discharge
por: Mercuro, Nicholas J., et al.
Publicado: (2022)

Pharmacist care in hypertension management: systematic review of randomized controlled trials
por: Gastens, V, et al.
Publicado: (2022)

Pharmacist care in hypertension management: systematic review of randomized controlled trials
por: Gastens, V, et al.
Publicado: (2023)

Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes
por: So, Randy, et al.
Publicado: (2021)

Primary healthcare policy and vision for community pharmacy and pharmacists in the United States
por: Salgado, Teresa M., et al.
Publicado: (2020)

Open access and predatory publishing: a survey of the publishing practices of academic pharmacists and nurses in the United States
por: Conlogue, Bridget C., et al.
Publicado: (2022)

Real-world implementation of diabetes management by pharmacists: The R(X)ING Practice Tool
por: Al Hamarneh, Yazid N., et al.
Publicado: (2021)

Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017
por: Powis, Kathleen M., et al.
Publicado: (2019)

Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017
por: Cheng, Xingxing S., et al.
Publicado: (2022)

R(x)IALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre–post intervention study
por: Al Hamarneh, Yazid N, et al.
Publicado: (2021)

Learning to prescribe – pharmacists' experiences of supplementary prescribing training in England
por: Cooper, Richard J, et al.
Publicado: (2008)

Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care
por: Bungard, Tammy J, et al.
Publicado: (2009)

Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States
por: Belletti, Daniel A, et al.
Publicado: (2010)

Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan
por: Rafferty, Ellen, et al.
Publicado: (2018)

Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan
por: Rafferty, Ellen, et al.
Publicado: (2017)

Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States
por: Winkelman, Tyler N. A., et al.
Publicado: (2018)

Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States
por: Tatar, Moosa, et al.
Publicado: (2020)

Using scenarios to test the appropriateness of pharmacist prescribing in asthma management
por: Hanna, Tamer, et al.
Publicado: (2014)

Predictors of job satisfaction among pharmacists: A regional workforce survey
por: Radwan, Rotana M., et al.
Publicado: (2022)

Association of State Opioid Duration Limits With Postoperative Opioid Prescribing
por: Agarwal, Sunil, et al.
Publicado: (2019)

Inpatient Oral Anticoagulation Management by Clinical Pharmacists: Safety and Cost effectiveness
por: Hosmane, Sharath R., et al.
Publicado: (2010)

Pharmacist intervention for glycaemic control in the community (the RxING study)
por: Al Hamarneh, Yazid N, et al.
Publicado: (2013)

A pharmacist’s guide to human papillomavirus (HPV)
por: Cable, Cheryl E., et al.
Publicado: (2022)

The case of pharmacist prescribing policy in Israel
por: Yariv, Hila
Publicado: (2015)

Mental health pharmacists as interim prescribers
por: Gibu, Matthew, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_itn3skkbm700lb2269n0h4olle